Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20288Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Maranis, S. | en |
| dc.contributor.author | Tsouli, S. | en |
| dc.contributor.author | Konitsiotis, S. | en |
| dc.date.accessioned | 2015-11-24T19:06:02Z | - |
| dc.date.available | 2015-11-24T19:06:02Z | - |
| dc.identifier.issn | 1878-4216 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20288 | - |
| dc.rights | Default Licence | - |
| dc.title | Treatment of motor symptoms in advanced Parkinson's disease: a practical approach | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1016/j.pnpbp.2011.05.014 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21645577 | - |
| heal.identifier.secondary | http://ac.els-cdn.com/S0278584611001849/1-s2.0-S0278584611001849-main.pdf?_tid=8858a22248e645e870e1570a3996194e&acdnat=1332840531_31056385c3237a131e2fa1c86a129415 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2011 | - |
| heal.abstract | Patients with advanced Parkinson's disease (PD) are known to develop motor complications after a few years of levodopa (L-dopa) therapy. Motor fluctuations develop with increasing severity of the disease, owing to loss of dopaminergic neurons and loss of the buffering capacity of the neurons to fluctuating dopamine levels. Dyskinesias develop as a result of pulsatile stimulation of the receptors and alterations in neuronal firing patterns. L-dopa remains the gold standard medication for the treatment of patients with advanced PD. However, once motor complications on L-dopa therapy emerge, clinicians may add on other classes of antiparkinsonian drugs such as dopamine agonists, catechol-O-methyl transferase inhibitors (COMTIs) or monoamine oxidase type B inhibitors (MAOBIs). The individualisation of the treatment seems to be the key for the best approach of advanced PD patients. The present review provides the most important current clinical data in the pharmacological treatment of motor symptoms in advanced PD and provides the clinician a simple algorithm in order to determine the best suitable treatment to advanced parkinsonian patients. | en |
| heal.journalName | Prog Neuropsychopharmacol Biol Psychiatry | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Maranis-2011-Treatment of motor s.pdf | 461.26 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
